Seroquel XR in Schizophrenia Relapse Prevention

CompletedOBSERVATIONAL
Enrollment

1,600

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Schizophrenia Relapse Prevention
Trial Locations (48)

Unknown

Research Site, Baja

Research Site, Barcs

Research Site, Budapest

Research Site, Cegléd

Research Site, Debrecen

Research Site, Dombóvár

Research Site, Dunaújváros

Research Site, Eger

Research Site, Egerszalók

Research Site, Emőd

Research Site, Esztergom

Research Site, Érd

Research Site, Gödöllő

Research Site, Gyöngyös

Research Site, Győr

Research Site, Gyula

Research Site, Heves

Research Site, Hódmezővásárhely

Research Site, Jánoshalma

Research Site, Jászberény

Research Site, Kalocsa

Research Site, Kecskemét

Research Site, Kétegyháza

Research Site, Kiskunhalas

Research Site, Kistokaj

Research Site, Miskolc

Research Site, Nagyatád

Research Site, Nagykanizsa

Research Site, Nagykálló

Research Site, Nagykőrös

Research Site, Orosháza

Research Site, Pécs

Research Site, Pomáz

Research Site, Sátoraljaújhely

Research Site, Soltvadkert

Research Site, Sopron

Research Site, Sümeg

Research Site, Szeged

Research Site, Szeghalom

Research Site, Szekszárd

Research Site, Szentes

Research Site, Székesfehérvár

Research Site, Szigetszentmiklós

Research Site, Szigetvár

Research Site, Szolnok

Research Site, Szombathely

Research Site, Tatabánya

Research Site, Veszprém

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY